Division of Neurology, Department of Medicine, Jichi Medical University School of Medicine.
Department of Neurological Science, Graduate School of Medicine, Nippon Medical School.
J Atheroscler Thromb. 2023 Nov 1;30(11):1703-1714. doi: 10.5551/jat.64079. Epub 2023 Apr 20.
Studies investigating the relationship between pulse pressure (PP) and prognosis in acute ischemic stroke remain limited. Thus, in this study, we aim to determine whether changes in PP in the early phase of ischemic stroke are associated with neurological deterioration or stroke recurrence.
Patients who participated in the Acute Aspirin Plus Cilostazol Dual Therapy for Non-cardiogenic Stroke Patients Within 48 Hours of Symptom Onset (ADS) trial were included in this study. We then divided the patients into four groups (low-low, low-high, high-low, high-high) according to low or high PP both on admission and 24 h after admission. The threshold PP calculated by receiver operating characteristic curve analysis of PP on admission for neurological deterioration within 14 days and recurrent ischemic stroke/transient ischemic attack (TIA) within 3 months was 69 mmHg.
Neurological deterioration within 14 days was observed in 118 patients (10.6%), whereas recurrent ischemic stroke/TIA within 3 months was noted in 34 patients (3.2%). Among these four groups, both neurological deterioration within 14 days (odds ratio [OR] 2.09, 95% confidence interval [CI] 1.12-3.91; p=0.0209) and recurrent ischemic stroke/TIA within 3 months (OR 4.80; 95% CI 1.62-14.86; p=0.0064) were significantly more frequent in the high-high group than in the low-low group as per the results of our multivariate analysis. In addition, neurological deterioration within 14 days was significantly higher in the high-low group than that in the low-low group (OR 2.70; 95% CI 1.44-5.05; p=0.0019).
High PP during the acute phase of ischemic stroke appears to be associated with ischemic stroke recurrence and neurological deterioration, particularly if PP is elevated both on admission and 24 h later after admission.
研究脉搏压(PP)与急性缺血性脑卒中预后之间关系的研究仍然有限。因此,在本研究中,我们旨在确定缺血性脑卒中早期 PP 的变化是否与神经功能恶化或脑卒中复发有关。
本研究纳入了参与急性阿司匹林加西洛他唑双重治疗非心源性卒中患者(ADS)试验的患者。然后,我们根据入院时和入院后 24 小时的低或高 PP 将患者分为四组(低-低、低-高、高-低、高-高)。通过入院时 PP 的受试者工作特征曲线分析,计算出用于预测 14 天内神经功能恶化和 3 个月内复发性缺血性卒中和短暂性脑缺血发作(TIA)的阈值 PP 为 69mmHg。
118 例患者(10.6%)在 14 天内出现神经功能恶化,34 例患者(3.2%)在 3 个月内发生复发性缺血性卒中和 TIA。在这四组中,14 天内神经功能恶化(比值比[OR]2.09,95%置信区间[CI]1.12-3.91;p=0.0209)和 3 个月内复发性缺血性卒中和 TIA(OR 4.80;95% CI 1.62-14.86;p=0.0064)在高-高组均明显高于低-低组,这是我们多变量分析的结果。此外,与低-低组相比,高-低组 14 天内神经功能恶化的发生率明显更高(OR 2.70;95% CI 1.44-5.05;p=0.0019)。
缺血性脑卒中急性期的高 PP 似乎与缺血性脑卒中复发和神经功能恶化有关,尤其是如果入院时和入院后 24 小时的 PP 均升高。